Identifying and characterizing somatic/germline genetic changes relevant to cancer initiation and progression as well as drug response by integrating various data types, including DNA, RNA and proteomics data. Developing algorithms to facilitate the translation of genomic findings to clinical practice.
- 1998: PhD, biochemistry, University of Utah, Salt Lake City
- 1998 - 2999: Postdoctoral fellow, biochemistry, Stanford University, Palo Alto, Calif.
Disclaimer: This listing may not include all articles associated with this physician and may include publications related to other physicians with a similar name.